D
Discoveric Bio designs fully human bi- and multispecific antibodies for therapeutic applications in Alzheimer’s disease and antimicrobial‑resistant infections. Their platform focuses on natural antibody formats that enable safe, selective targeting of disease‑relevant pathways such as CD47. The company partners with pharma and biotech firms to advance these next‑generation antibody candidates from research through clinical development.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Discoveric Bio designs fully human bi- and multispecific antibodies for therapeutic applications in Alzheimer’s disease and antimicrobial‑resistant infections. Their platform focuses on natural antibody formats that enable safe, selective targeting of disease‑relevant pathways such as CD47. The company partners with pharma and biotech firms to advance these next‑generation antibody candidates from research through clinical development.